Bayer HealthCare AG has entered into a worldwide, non-exclusive license agreement with Millipore to use its UCOE (Ubiquitous Chromatin Opening Element) technology to manufacture its biologic drugs. The license will enable Bayer to manufacture recombinant proteins in mammalian cells more efficiently by generating higher protein yields in its upstream bioprocessing operations. Financial terms were not disclosed.     Bayer HealthCare, based in Leverkusen, Germany, includes Animal Health, Consum...